Skip to content

Histogen Inc.: 10-Q filed 2014-05-14

What Histogen Inc. reported in its quarterly report filed 2014-05-14 (fiscal Q1 2014): 29 published measures, 73 facts as tagged in accession 0001193125-14-199043.

This filing

Form
10-Q (quarterly report)
Filed
2014-05-14
Fiscal period
fiscal Q1 2014
Accession
0001193125-14-199043 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All Histogen Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2014-03-3151,879,210USD
At 2013-12-3156,935,954USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2014-03-3148,262,691USD
At 2013-12-3153,118,950USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2014-03-312,485,662USD
At 2013-12-314,158,953USD
At 2013-03-314,840,486USD
At 2012-12-314,036,091USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2014-01-01 to 2014-03-31-5,243,356USD90
2005-07-13 to 2014-03-31-79,667,357USD3184
2013-01-01 to 2013-03-31-2,296,783USD90

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2014-01-01 to 2014-03-3112,918USD90
2005-07-13 to 2014-03-31245,698USD3184

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2014-01-01 to 2014-03-31-0.34USD/shares90
2013-01-01 to 2013-03-31-2.17USD/shares90

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2014-01-01 to 2014-03-31-0.34USD/shares90
2013-01-01 to 2013-03-31-2.17USD/shares90

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2014-03-3132,630USD
At 2013-12-3123,068USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2014-01-01 to 2014-03-31379,433USD90
2005-07-13 to 2014-03-311,034,266USD3184
2013-01-01 to 2013-03-3121,418USD90

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2014-03-3151,769,204USD
At 2013-12-3156,898,491USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2014-01-01 to 2014-03-3117,500USD90
2005-07-13 to 2014-03-311,254,899USD3184
2013-01-01 to 2013-03-3117,500USD90

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2014-03-312,616,519USD
At 2013-12-312,817,004USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2014-01-01 to 2014-03-315,245,845USD90
2005-07-13 to 2014-03-3175,785,831USD3184
2013-01-01 to 2013-03-311,716,574USD90

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2014-01-01 to 2014-03-313,650,598USD90
2005-07-13 to 2014-03-3151,423,185USD3184
2013-01-01 to 2013-03-31967,778USD90

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2014-03-3115,424,320shares
At 2013-12-3115,386,542shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2014-03-31127,936,873USD
At 2013-12-31127,536,408USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2014-03-31-1,874USD
At 2013-12-3111,497USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2014-03-31228,548USD
At 2013-12-31215,631USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2014-03-31195,918USD
At 2013-12-31192,563USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2014-03-3177,376USD
At 2013-12-3114,395USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2014-03-31687,164USD
At 2013-12-31545,504USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2014-01-01 to 2014-03-31-5,256,727USD90
2005-07-13 to 2014-03-31-79,669,231USD3184
2013-01-01 to 2013-03-31-2,297,334USD90

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2014-01-01 to 2014-03-31-5,243,356USD90
2005-07-13 to 2014-03-31-68,650,875USD3184
2013-01-01 to 2013-03-31-2,296,783USD90

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2014-01-01 to 2014-03-311,595,247USD90
2005-07-13 to 2014-03-3124,362,646USD3184
2013-01-01 to 2013-03-31748,796USD90

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2014-01-01 to 2014-03-313,356USD90
2005-07-13 to 2014-03-31213,068USD3184
2013-01-01 to 2013-03-312,698USD90

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2014-01-01 to 2014-03-31-784USD90
2005-07-13 to 2014-03-31239,545USD3184
2013-01-01 to 2013-03-31-15,677USD90

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2014-01-01 to 2014-03-312,489USD90
2005-07-13 to 2014-03-31-3,881,526USD3184
2013-01-01 to 2013-03-31-580,209USD90

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2014-01-01 to 2014-03-3117,500USD90
2005-07-13 to 2014-03-31275,639USD3184
2013-01-01 to 2013-03-3117,500USD90

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2014-01-01 to 2014-03-3112,000USD90
2005-07-13 to 2014-03-31139,578USD3184
2013-01-01 to 2013-03-3110,730USD90

Inspect the source

Entity
Histogen Inc. / CIK 0001383701
Captured
SEC response SHA-256
1b0bdbacf46387bf523b0442b66eb6b2b6067a55baf63fbbb623543f2333fbd7

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001383701.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))